Tele: 561.316.3330
Breaking Medical Device News

Sunday, October 17, 2021
HomeIdentiv Inc.Identiv Awarded Schreiner Group "Supplier of the Year"

Identiv Awarded Schreiner Group “Supplier of the Year”

March 31, 2021

Identiv, Inc., a global leader in digital identification and security, today announced it is awarded “Supplier of the Year” by Schreiner Group GmbH & Co. KG for its innovative device-level authentication, anti-counterfeiting RFID devices in medical equipment, and consumables.

These RFID inlays also work with hospital medical devices currently used in applications including treating patients suffering from COVID-19 and other respiratory conditions, as well as authenticating consumables for analytical equipment.

This year marks the ninth time Schreiner Group has recognized their best supplier in terms of on-time delivery, quality, pricing, and customer service. It is also the first time a supplier of radio-frequency identification (RFID) devices received the honor. The acknowledgment is attributed to Identiv’s high compliance score: the company earned 95 out of 100 points and is rated an “A” supplier, joining well-known prior recipients like 3M and FLEXcon. It is a particularly notable achievement in a year dominated by widespread disruptions in logistics and supply chain paired with an unforecasted high demand for authentication products.

The two companies have worked together for over 15 years and Identiv is currently supplying RFID devices to Schreiner Group through 2023 to provide secure authentication in the Internet of Things (IoT), with several million RFID devices from its technology portfolio already deployed and connected to high-tech labels and one-time-use medical equipment in hospitals throughout Europe. Identiv’s RFID Inlays provide contactless device identification, optimize processes during medical procedures (i.e., checking for compatibility between different types of equipment), and protect patients’ health and safety from counterfeits.

“Our commitment to exceptional technology and service has been recognized by the Schreiner Group,” said Dr. Manfred Mueller, Identiv COO, and General Manager Identity. “Authentication and anti-counterfeiting applications have become even more critical over the past year, especially in the healthcare sector where organizations are continuously grappling with protecting their patients and employees during the pandemic.”

“At Schreiner Group, we recognize our outstanding partners who help us provide our customers with intelligent solutions that optimize processes and enhance product safety,” said Manfred Laschinger, Schreiner Group GmbH Head of Corporate Purchasing. “Continuing to work with Identiv allows us to do just that.”

Identiv’s comprehensive RFID design portfolio verifies smart identities and security in the IoT. It’s high-frequency (HF) and ultra-high frequency (UHF) 13.56 MHz RFID devices are customizable, are available as dry or wet inlays, and come in various shapes and sizes. The RFID devices feature multiple designs integrating various materials, chip technologies, and frequencies for metal and non-metal environments. Identiv produces RFID devices using advanced flip-chip technology and state-of-the-art, high-volume die-bonding processes with integrated inline quality and process control to guarantee superior quality performance.

This IoT portfolio powers RFID and near field communication (NFC) technology for medical devices, wearables, mobile peripherals, smart posters and tags, pharmaceuticals and pharmacies, luxury goods, government-controlled products, logistics and supply chains, customer engagement, libraries, asset management, electronic games, event management, athletic wear, and more.

The official Schreiner Group award ceremony will be held later this year once the pandemic-related restrictions allow for face-to-face meetings. More here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy